Psychometric properties of the VSQLQ in black patients with mild hypertension

Journal of the National Medical Association

Volumn 92, Issue 12, 2000, Pages 550-557

  Leidy, Nancy Kline ^a   Schmier, Jordana K ^a   Bonomi, Amy E ^b   Legro, Marcia ^c   Zyczynski, Teresa ^d   Kong, B Waine ^e  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b CENTER FOR HEALTH STUDIES   (United States)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^d ASTRAZENECA   (United Kingdom)

^e Association of Black Cardiologists   (United States)

Author keywords

Health related quality of life; Hypertension; VSQLQ

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HOSPITALIZATION; HUMAN; HYPERTENSION; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; NEGRO; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 0034568301     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Sytkowski PA, D'Acostino RB, Belanger AJ, Kannel WB. Secular trends in long-term sustained hypertension, long-term treatment and cardiovascular mortality. The Framingham Heart Study 1950 to 1990. Circulation. 1996;93:697-703.
2. He J, Whelton PK. Epidemiology and prevention of hypertension. Med Clin North Am. 1997;81:1077-1097.
3. Pardell H, Armario P, Hernandez R, Tresserras R. Hypertension: epidemiology and cost of illness. Dis Manage Health Outcomes. 1997;1:135-140.
4. Wilson PW. An epidemiologic perspective of systemic hypertension, ischemic heart disease, and heart failure. Am J Cardiol. 1997;80:3J-8J.
5. Burt VL, Cutler JA, Higgins M, et al. Trends in the prevalence, awareness, treatment and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension. 1995;26:60-69.
6. Hjemdahl P, Wiklund IK. Quality of life on antihypertensive drug therapy: scientific end-point or marketing exercise? Current Science. 1992;10:1437-1446.
7. Bulpitt CH, Fletcher AE. Quality of life and the heart: evaluation of therapeutic alternatives. Br J Clin Pract. 1994;73:18-22.
8. Stewart AL, Greenfield S, Hays RD, et al. Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. JAMA. 1989;262:907-913.
9. Chambers JW, Kong BW. Assessing quality of life: construction and validation of a scale. In: Jones R, ed. Handbook of Test and Measurement for Black Populations. Hampton, VA: Cobb & Henry Publishers; 1996:335-346.
10. Kong BW, Clive J, Kong SH. Quality of life as a vital clinical sign. J Hum Hypertens. 1990;4:121-123.
11. Zyczynski T, Leidy NK, Jamerson K, et al. Health-related quality of life (HRQL) outcomes of candesartan cilexetil versus placebo in black patients with mild systemic hypertension: the ABC Trial. Heart Disease. 2000: in press.
12. Kong BW, Bean JA, Stephens D. Assessment of the Vital Signs Quality of Life Questionnaire in three studies on hypertension. J Hum Hypertens. 1995;9:255-262.
13. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. Boston, MA: The Health Institute, New England Medical Center, 1993.
14. Ware JE, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scales: a User Manual. Boston, MA: The Health Institute, New England Medical Center, 1994.
15. Ware JE, Bayliss MS, Rogers WH, Kosinski M, Tarlov AR. Differences in 4-year health outcomes for elderly and poor, chronically ill patients treated in HMO and fee-for-service systems. JAMA. 1996;276:1039-1047.
16. Wolinsky FD, Stump TE. A measurement model of the Medical Outcomes Study 36-Item Short-Form Health Survey in a clinical sample of disadvantaged, older, black, and white men and women. Med Care. 1996;34:537-548.
17. Lyons RA, Lo SV, Littlepage BNC. Comparative health status of patients with 11 common illnesses in Wales. J Epidemiol Community Health. 1994;48:388-390.
18. Fryback DG, Dasbach EJ, Klein R, et al. The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making. 1993;13:89-102.
19. Krousel-Wood MA, Re RN. Health status assessment in a hypertension section of an internal medicine clinic. Am J Med Sci. 1994;308:211-217.
20. Kusek JW, Lee JY, Smith DE, et al. Effect of blood pressure control and antihypertensive drug regimen on quality of life: the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials. 1996;17(suppl 4):40S-46S.
21. Lawrence WF, Fryback DG, Matrin PA, Klein R, Klein BEK. Health status and hypertension: a population-based study. J Clin Epidemiol. 1996;49:1239-1245.
22. DeForge BR, Stewart DL, DeVoe-Weston M, Graham L, Charleston J. The relationship between health status and blood pressure in urban African Americans. J Natl Med Assoc. 1998;90: 658-664.
23. Jaeschke R, Singer J, Guyatt GH. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10: 407-415.
24. Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol 1994;1:81-87.
25. Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE. Measuring quality of life in asthma. Am Rev Respir Dis. 1993;147:823-838.
26. Leidy NK, Coughlin C. Psychometric performance of the Asthma Quality of Life Questionnaire in a US sample. Qual Life Res. 1998;7:127-134.
27. Bonomi AE, Legro MW, Leidy NK, Zyczynski T, McGann M, Ajax M. Maximizing quality in quality of life outcomes research: a multifaceted approach for clinical trials [Abstract]. Qual Life Res. 1998;7:574.
28. Nunnally JC, Bernstein IH. Psychometric Theory, 3rd ed. New York: McGraw-Hill, 1994.
29. Linzer M, Spitzer R, Kroenke K, et al. Gender, quality of life, and mental disorders in primary care: results from the PRIME-MD 1000 study. Am J Med. 1996;101:526-533.
30. Osborne ML, Vollmer WM, Linton KL, Buist AS. Characteristics of patients with asthma within a large HMO: a comparison by age and gender. Am J Respir Crit Care Med. 1998;157: 123-128.
31. Garg N, Yates WR, Jones R, Zhou M, Williams S. Effect of gender, treatment site and psychiatric comorbidity on quality of life outcome in substance dependence. Am J Addict. 1999;8:44-54.
32. Lewin AJ, Lueg MC, Targum S, Cardenas P. A clinical trial evaluating the 24-hour effects of bisoprolol/hydrochlorothiazide 5 mg/6.25 mg combination in patients with mild to moderate hypertension. Clin Cardial 1993;16:732-736.
33. Levy B, Rosenberg L, Colasante D, Deitch M. A comparison of two structurally distinct types of calcium channel blockers in the treatment of patients with mild to moderate hypertension. Drug Invest. 1993;5:289-295.
34. Neutel JM, Smith DG, Lofkowitz MP, Cargo P, Alemayelau D, Weber MA. A long-acting formulation of verapamil in the treatment of hypertension in the elderly [Abstract]. Am J Hypertens. 1993;6:123A.
35. Schoenberger JA, Weir MR, Wolfson PM, et al. A placebo controlled study of verapamil in the treatment of hypertension in the elderly [Abstract]. Am J Hypertens. 1993;6(5 part 2): 123A.